ID   PROSC_HUMAN             Reviewed;         275 AA.
AC   O94903; Q6FI94;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   10-MAY-2017, entry version 150.
DE   RecName: Full=Proline synthase co-transcribed bacterial homolog protein;
GN   Name=PROSC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10496079; DOI=10.1007/s100380050172;
RA   Ikegawa S., Isomura M., Koshizuka Y., Nakamura Y.;
RT   "Cloning and characterization of human and mouse PROSC (proline
RT   synthetase co-transcribed) genes.";
RL   J. Hum. Genet. 44:337-342(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6 AND SER-244, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226 AND SER-244, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   INVOLVEMENT IN EPVB6D, FUNCTION, VARIANTS EPVB6D 71-GLN--HIS-275 DEL;
RP   78-SER--HIS-275 DEL; LEU-87; PRO-175 AND GLN-241, AND CHARACTERIZATION
RP   OF VARIANTS EPVB6D 78-SER--HIS-275 DEL AND PRO-175.
RX   PubMed=27912044; DOI=10.1016/j.ajhg.2016.10.011;
RA   Darin N., Reid E., Prunetti L., Samuelsson L., Husain R.A., Wilson M.,
RA   El Yacoubi B., Footitt E., Chong W.K., Wilson L.C., Prunty H.,
RA   Pope S., Heales S., Lascelles K., Champion M., Wassmer E.,
RA   Veggiotti P., de Crecy-Lagard V., Mills P.B., Clayton P.T.;
RT   "Mutations in PROSC disrupt cellular pyridoxal phosphate homeostasis
RT   and cause vitamin-B6-dependent epilepsy.";
RL   Am. J. Hum. Genet. 99:1325-1337(2016).
CC   -!- FUNCTION: May be involved in intracellular homeostatic regulation
CC       of pyridoxal 5'-phosphate (PLP), the active form of vitamin B6.
CC       {ECO:0000269|PubMed:27912044}.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000250};
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DISEASE: Epilepsy, early-onset, vitamin B6-dependent (EPVB6D)
CC       [MIM:617290]: An autosomal recessive neurologic disorder
CC       characterized by seizures responsive to treatment with activated
CC       vitamin B6 and/or pyridoxine. Most patients show delayed
CC       psychomotor development, mental retardation and learning
CC       disability. Seizures onset is in the first days or months of life.
CC       {ECO:0000269|PubMed:27912044}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the pyridoxal phosphate-binding protein
CC       YggS/PROSC family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB018566; BAA36842.1; -; Genomic_DNA.
DR   EMBL; AL136616; CAB66551.1; -; mRNA.
DR   EMBL; CR533532; CAG38563.1; -; mRNA.
DR   EMBL; BC012334; AAH12334.1; -; mRNA.
DR   CCDS; CCDS6096.1; -.
DR   RefSeq; NP_009129.1; NM_007198.3.
DR   UniGene; Hs.304792; -.
DR   UniGene; Hs.608177; -.
DR   ProteinModelPortal; O94903; -.
DR   SMR; O94903; -.
DR   BioGrid; 116381; 66.
DR   IntAct; O94903; 13.
DR   MINT; MINT-3002521; -.
DR   STRING; 9606.ENSP00000333551; -.
DR   DrugBank; DB00172; L-Proline.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   iPTMnet; O94903; -.
DR   PhosphoSitePlus; O94903; -.
DR   BioMuta; PROSC; -.
DR   UCD-2DPAGE; O94903; -.
DR   EPD; O94903; -.
DR   MaxQB; O94903; -.
DR   PaxDb; O94903; -.
DR   PeptideAtlas; O94903; -.
DR   PRIDE; O94903; -.
DR   DNASU; 11212; -.
DR   Ensembl; ENST00000328195; ENSP00000333551; ENSG00000147471.
DR   GeneID; 11212; -.
DR   KEGG; hsa:11212; -.
DR   UCSC; uc003xkh.4; human.
DR   CTD; 11212; -.
DR   GeneCards; PROSC; -.
DR   HGNC; HGNC:9457; PROSC.
DR   HPA; CAB017033; -.
DR   HPA; HPA023646; -.
DR   HPA; HPA023733; -.
DR   MIM; 604436; gene.
DR   MIM; 617290; phenotype.
DR   neXtProt; NX_O94903; -.
DR   OpenTargets; ENSG00000147471; -.
DR   PharmGKB; PA33810; -.
DR   eggNOG; KOG3157; Eukaryota.
DR   eggNOG; COG0325; LUCA.
DR   GeneTree; ENSGT00390000004928; -.
DR   HOVERGEN; HBG053692; -.
DR   InParanoid; O94903; -.
DR   KO; K06997; -.
DR   OMA; HGSTMVR; -.
DR   OrthoDB; EOG091G0IMD; -.
DR   PhylomeDB; O94903; -.
DR   TreeFam; TF314637; -.
DR   ChiTaRS; PROSC; human.
DR   GeneWiki; PROSC; -.
DR   GenomeRNAi; 11212; -.
DR   PRO; PR:O94903; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000147471; -.
DR   CleanEx; HS_PROSC; -.
DR   ExpressionAtlas; O94903; baseline and differential.
DR   Genevisible; O94903; HS.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IDA:LIFEdb.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IBA:GO_Central.
DR   Gene3D; 3.20.20.10; -; 1.
DR   HAMAP; MF_02087; PLP_homeostasis; 1.
DR   InterPro; IPR001608; Ala_racemase_N.
DR   InterPro; IPR011078; COG0325_fam.
DR   InterPro; IPR029066; PLP-binding_barrel.
DR   PANTHER; PTHR10146; PTHR10146; 1.
DR   Pfam; PF01168; Ala_racemase_N; 1.
DR   PIRSF; PIRSF004848; YBL036c_PLPDEIII; 1.
DR   SUPFAM; SSF51419; SSF51419; 1.
DR   TIGRFAMs; TIGR00044; TIGR00044; 1.
DR   PROSITE; PS01211; UPF0001; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; Epilepsy; Phosphoprotein;
KW   Polymorphism; Pyridoxal phosphate; Reference proteome.
FT   CHAIN         1    275       Proline synthase co-transcribed bacterial
FT                                homolog protein.
FT                                /FTId=PRO_0000163210.
FT   MOD_RES       6      6       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      47     47       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000250}.
FT   MOD_RES      69     69       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9Z2Y8}.
FT   MOD_RES     125    125       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9Z2Y8}.
FT   MOD_RES     226    226       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     244    244       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VARIANT      24     24       V -> M (in dbSNP:rs35423325).
FT                                /FTId=VAR_052476.
FT   VARIANT      71    275       Missing (in EPVB6D).
FT                                {ECO:0000269|PubMed:27912044}.
FT                                /FTId=VAR_078004.
FT   VARIANT      78    275       Missing (in EPVB6D; decreased expression
FT                                at the mRNA level; undetectable at the
FT                                protein level in patient's fibroblasts).
FT                                {ECO:0000269|PubMed:27912044}.
FT                                /FTId=VAR_078005.
FT   VARIANT      87     87       P -> L (in EPVB6D).
FT                                {ECO:0000269|PubMed:27912044}.
FT                                /FTId=VAR_078006.
FT   VARIANT     175    175       L -> P (in EPVB6D; decreased expression
FT                                at the mRNA level; undetectable at the
FT                                protein level in patient's fibroblasts).
FT                                {ECO:0000269|PubMed:27912044}.
FT                                /FTId=VAR_078007.
FT   VARIANT     241    241       R -> Q (in EPVB6D).
FT                                {ECO:0000269|PubMed:27912044}.
FT                                /FTId=VAR_078008.
SQ   SEQUENCE   275 AA;  30344 MW;  A81049432B1A8732 CRC64;
     MWRAGSMSAE LGVGCALRAV NERVQQAVAR RPRDLPAIQP RLVAVSKTKP ADMVIEAYGH
     GQRTFGENYV QELLEKASNP KILSLCPEIK WHFIGHLQKQ NVNKLMAVPN LFMLETVDSV
     KLADKVNSSW QRKGSPERLK VMVQINTSGE ESKHGLPPSE TIAIVEHINA KCPNLEFVGL
     MTIGSFGHDL SQGPNPDFQL LLSLREELCK KLNIPADQVE LSMGMSADFQ HAVEVGSTNV
     RIGSTIFGER DYSKKPTPDK CAADVKAPLE VAQEH
//
